Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells (Q36689109)

15 August 2017

1 reference

title

Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells (English)

1 reference

15 August 2017

Angela Wahl

1

1 reference

PubMed ID

17181478

15 August 2017

Jon Weidanz

series ordinal

2

1 reference

PubMed ID

17181478

15 August 2017

William Hildebrand

series ordinal

3

1 reference

15 August 2017

1 December 2006

1 reference

Expert Review of Proteomics

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

6

1 reference

15 August 2017

641-652

1 reference

Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Population biology of antigen presentation by MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Antigen processing is predictable: From genes to T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Prediction of proteasome cleavage motifs by neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Prediction of MHC class I binding peptides using profile motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

The use of HPLC-MS in T-cell epitope identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Disparate binding of chaperone proteins by HLA-A subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

New HLA-A, -B, and -C locus-specific primers for PCR amplification from cDNA: application in clinical immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Dominance and crypticity of T cell antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

Self-Peptides with Intermediate Capacity to Bind and Stabilize MHC Class I Molecules may be Immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.6.641

21 January 2018

Identifiers

DOI

10.1586/14789450.3.6.641

1 reference

15 August 2017

1 reference

PubMed ID

17181478